AbbVie Inc. (4AB.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 409.2B |
| Enterprise Value | 473.04B |
| P/E Ratio | 50.6 |
| PEG Ratio | 0.15 |
| Price/Sales Ratio | 7.9 |
| Price/Book Ratio | -114.05 |
| Enterprise/Revenue | 8.96 |
| Enterprise/EBITDA | 24.49 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.16 |
| Operating Margin | 0.36 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | -2.03 |
Income Statement
| Revenue | 61.16B |
| Revenue/Share | 37.25 |
| Gross Profit | 42.96B |
| EBITDA | 17.63B |
| Net Income | 4.23B |
| Diluted EPS | 2.36 |
Balance Sheet
| Total Cash | 10.77B |
| Total Cash/Share | 6.08 |
| Total Debt | 80.9B |
| Total Debt/Equity | -17.65 |
| Current Ratio | 0.87 |
| Book Value Per Share | -2.56 |
Price History
| 52-Week Change | 36.99 |
| 52-Week High | 270.7 |
| 52-Week Low | 162.85 |
| Moving Average 50 Days | 241.16 |
| Moving Average 200 Days | 208.29 |
Statistics
| Average Volume | 605 |
| Shares Outstanding | 1.77B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 6.92 |
| Trailing Annual Dividend Yield | 2.35 |
| Payout Ratio | 1.17 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
